Application
LYSMD4 Antibody (N-term) (Cat. #AP10422a) western blot analysis in MCF-7 cell line lysates (35ug/lane).This demonstrates the LYSMD4 antibody detected the LYSMD4 protein (arrow).Application
LYSMD4 Antibody (N-term) (Cat. #AP10422a) flow cytometric analysis of MCF-7 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | LYSMD4 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | LYSMD4; LysM and putative peptidoglycan-binding domain-containing protein 4 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | LYSMD4 LysM and putative peptidoglycan-binding domain-containing protein 4 |
|---|---|
| Molecular Weight(MW) | 32066 Da |
| Tissue Specificity | This LYSMD4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 40-69 amino acids from the N-terminal region of human LYSMD4. |
| Cellular Localization | Membrane; Single-pass membrane protein (Potential) |
| Entrez Gene | 145748 |
|---|---|
| Nucleotide Accession | NP_689662.2 |
Application
LYSMD4 Antibody (N-term) (Cat. #AP10422a) western blot analysis in MCF-7 cell line lysates (35ug/lane).This demonstrates the LYSMD4 antibody detected the LYSMD4 protein (arrow).
Application
LYSMD4 Antibody (N-term) (Cat. #AP10422a) flow cytometric analysis of MCF-7 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
